+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Biologics Contract Manufacturing Market Research Report by Product (Biosimilar, Insulin, and Interferons), Platform, Therapeutic Area, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 229 Pages
  • July 2022
  • Region: Global
  • 360iResearch™
  • ID: 5612898
UP TO OFF until Dec 31st 2022
The Global Biologics Contract Manufacturing Market size was estimated at USD 16.92 billion in 2021, USD 19.64 billion in 2022, and is projected to grow at a CAGR 16.32% to reach USD 41.92 billion by 2027.

Market Statistics:


The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Biologics Contract Manufacturing to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Product, the market was studied across Biosimilar, Insulin, Interferons, Monoclonal Antibodies, Recombinant Hormones, and Vaccines.
  • Based on Platform, the market was studied across Mammalian and Microbial.
  • Based on Therapeutic Area, the market was studied across Autoimmune Diseases, Cardiovascular Diseases, Infectious Diseases, Metabolic Diseases, Neurology, Oncology, Ophthalmology, and Respiratory Disorders.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Biologics Contract Manufacturing market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Biologics Contract Manufacturing Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Biologics Contract Manufacturing Market, including AbbVie, Inc., Abzena Plc., AGC Biologics, Ajinomoto Co., Inc., Avid Bioservices, Inc., Binex Co., Ltd., Boehringer Ingelheim GmbH, Cambrex Corporation, Catalent, Inc., Emergent BioSolutions Inc., Fujifilm Holding Corporation, JSR Life Sciences, LLC, Lonza Group AG, ProBioGen AG, Recipharm AB, Rentschler Biotechnologie GmbH, Samsung Biologics Co., Ltd., Siegfried Holding AG, Thermo Fisher Scientific, Inc., Toyobo Co. Ltd., and WuXi Biologics Inc..

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Biologics Contract Manufacturing Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Biologics Contract Manufacturing Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Biologics Contract Manufacturing Market?
4. What is the competitive strategic window for opportunities in the Global Biologics Contract Manufacturing Market?
5. What are the technology trends and regulatory frameworks in the Global Biologics Contract Manufacturing Market?
6. What is the market share of the leading vendors in the Global Biologics Contract Manufacturing Market?
7. What modes and strategic moves are considered suitable for entering the Global Biologics Contract Manufacturing Market?
Frequently Asked Questions about the Global Biologics Contract Manufacturing Market

What is the estimated value of the Global Biologics Contract Manufacturing Market?

The Global Biologics Contract Manufacturing Market was estimated to be valued at $16.92 Billion in 2021.

What is the growth rate of the Global Biologics Contract Manufacturing Market?

The growth rate of the Global Biologics Contract Manufacturing Market is 16.3%, with an estimated value of $41.92 Billion by 2027.

What is the forecasted size of the Global Biologics Contract Manufacturing Market?

The Global Biologics Contract Manufacturing Market is estimated to be worth $41.92 Billion by 2027.

Who are the key companies in the Global Biologics Contract Manufacturing Market?

Key companies in the Global Biologics Contract Manufacturing Market include AbbVie, Inc., Abzena Plc., AGC Biologics, Ajinomoto Co., Inc., Avid Bioservices, Inc., Binex Co., Ltd., Boehringer Ingelheim GmbH, Cambrex Corporation and Emergent BioSolutions Inc..

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing demand for biosimilars and vaccine production
5.1.1.2. Ongoing investment activities by CMOs for capacity expansion
5.1.1.3. Key advantages such as cost and time saving offered by contract services
5.1.2. Restraints
5.1.2.1. Changing trade policies between countries
5.1.3. Opportunities
5.1.3.1. Emergence of single-use bioprocessing equipment & solutions
5.1.3.2. Rising demand for cell and gene therapies for targeted treatment
5.1.4. Challenges
5.1.4.1. Concerns over the breach of intellectual property and patents
5.2. Cumulative Impact of COVID-19
6. Biologics Contract Manufacturing Market, by Product
6.1. Introduction
6.2. Biosimilar
6.3. Insulin
6.4. Interferons
6.5. Monoclonal Antibodies
6.6. Recombinant Hormones
6.7. Vaccines
7. Biologics Contract Manufacturing Market, by Platform
7.1. Introduction
7.2. Mammalian
7.3. Microbial
8. Biologics Contract Manufacturing Market, by Therapeutic Area
8.1. Introduction
8.2. Autoimmune Diseases
8.3. Cardiovascular Diseases
8.4. Infectious Diseases
8.5. Metabolic Diseases
8.6. Neurology
8.7. Oncology
8.8. Ophthalmology
8.9. Respiratory Disorders
9. Americas Biologics Contract Manufacturing Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Biologics Contract Manufacturing Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
11. Europe, Middle East & Africa Biologics Contract Manufacturing Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. AbbVie, Inc.
13.2. Abzena Plc.
13.3. AGC Biologics
13.4. Ajinomoto Co., Inc.
13.5. Avid Bioservices, Inc.
13.6. Binex Co., Ltd.
13.7. Boehringer Ingelheim GmbH
13.8. Cambrex Corporation
13.9. Catalent, Inc.
13.10. Emergent BioSolutions Inc.
13.11. Fujifilm Holding Corporation
13.12. JSR Life Sciences, LLC
13.13. Lonza Group AG
13.14. ProBioGen AG
13.15. Recipharm AB
13.16. Rentschler Biotechnologie GmbH
13.17. Samsung Biologics Co., Ltd.
13.18. Siegfried Holding AG
13.19. Thermo Fisher Scientific, Inc.
13.20. Toyobo Co. Ltd.
13.21. WuXi Biologics Inc.
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2021 VS 2027 (USD BILLION)
FIGURE 3. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 4. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2021 VS 2027 (%)
FIGURE 5. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2027
FIGURE 7. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET DYNAMICS
FIGURE 8. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2021 VS 2027 (%)
FIGURE 9. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2021 VS 2027 (USD BILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2027
FIGURE 11. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY BIOSIMILAR, 2019-2027 (USD BILLION)
FIGURE 12. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY BIOSIMILAR, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 13. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY INSULIN, 2019-2027 (USD BILLION)
FIGURE 14. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY INSULIN, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 15. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY INTERFERONS, 2019-2027 (USD BILLION)
FIGURE 16. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY INTERFERONS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 17. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2019-2027 (USD BILLION)
FIGURE 18. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 19. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY RECOMBINANT HORMONES, 2019-2027 (USD BILLION)
FIGURE 20. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY RECOMBINANT HORMONES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 21. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY VACCINES, 2019-2027 (USD BILLION)
FIGURE 22. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY VACCINES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 23. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PLATFORM, 2021 VS 2027 (%)
FIGURE 24. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PLATFORM, 2021 VS 2027 (USD BILLION)
FIGURE 25. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PLATFORM, 2027
FIGURE 26. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MAMMALIAN, 2019-2027 (USD BILLION)
FIGURE 27. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MAMMALIAN, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 28. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MICROBIAL, 2019-2027 (USD BILLION)
FIGURE 29. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MICROBIAL, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 30. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2021 VS 2027 (%)
FIGURE 31. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2021 VS 2027 (USD BILLION)
FIGURE 32. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2027
FIGURE 33. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY AUTOIMMUNE DISEASES, 2019-2027 (USD BILLION)
FIGURE 34. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 35. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2019-2027 (USD BILLION)
FIGURE 36. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 37. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY INFECTIOUS DISEASES, 2019-2027 (USD BILLION)
FIGURE 38. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 39. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY METABOLIC DISEASES, 2019-2027 (USD BILLION)
FIGURE 40. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY METABOLIC DISEASES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 41. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY NEUROLOGY, 2019-2027 (USD BILLION)
FIGURE 42. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY NEUROLOGY, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 43. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY ONCOLOGY, 2019-2027 (USD BILLION)
FIGURE 44. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY ONCOLOGY, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 45. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY OPHTHALMOLOGY, 2019-2027 (USD BILLION)
FIGURE 46. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 47. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY RESPIRATORY DISORDERS, 2019-2027 (USD BILLION)
FIGURE 48. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY RESPIRATORY DISORDERS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 49. AMERICAS BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 50. AMERICAS BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 51. AMERICAS BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
FIGURE 52. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2027
FIGURE 53. ARGENTINA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 54. BRAZIL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 55. CANADA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 56. MEXICO BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 57. UNITED STATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 58. UNITED STATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 59. UNITED STATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2021 VS 2027 (USD BILLION)
FIGURE 60. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2027
FIGURE 61. ASIA-PACIFIC BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 62. ASIA-PACIFIC BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 63. ASIA-PACIFIC BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
FIGURE 64. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2027
FIGURE 65. AUSTRALIA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 66. CHINA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 67. INDIA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 68. INDONESIA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 69. JAPAN BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 70. MALAYSIA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 71. PHILIPPINES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 72. SINGAPORE BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 73. SOUTH KOREA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 74. TAIWAN BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 75. THAILAND BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 76. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 77. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 78. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
FIGURE 79. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2027
FIGURE 80. FRANCE BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 81. GERMANY BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 82. ITALY BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 83. NETHERLANDS BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 84. QATAR BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 85. RUSSIA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 86. SAUDI ARABIA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 87. SOUTH AFRICA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 88. SPAIN BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 89. UNITED ARAB EMIRATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 90. UNITED KINGDOM BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 91. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 92. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 93. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 4. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2019-2027 (USD BILLION)
TABLE 5. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 6. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY BIOSIMILAR, BY REGION, 2019-2027 (USD BILLION)
TABLE 7. AMERICAS BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY BIOSIMILAR, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 8. UNITED STATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY BIOSIMILAR, BY STATE, 2019-2027 (USD BILLION)
TABLE 9. ASIA-PACIFIC BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY BIOSIMILAR, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 10. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY BIOSIMILAR, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 11. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY INSULIN, BY REGION, 2019-2027 (USD BILLION)
TABLE 12. AMERICAS BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY INSULIN, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 13. UNITED STATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY INSULIN, BY STATE, 2019-2027 (USD BILLION)
TABLE 14. ASIA-PACIFIC BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY INSULIN, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 15. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY INSULIN, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 16. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY INTERFERONS, BY REGION, 2019-2027 (USD BILLION)
TABLE 17. AMERICAS BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY INTERFERONS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 18. UNITED STATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY INTERFERONS, BY STATE, 2019-2027 (USD BILLION)
TABLE 19. ASIA-PACIFIC BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY INTERFERONS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 20. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY INTERFERONS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 21. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2019-2027 (USD BILLION)
TABLE 22. AMERICAS BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 23. UNITED STATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY STATE, 2019-2027 (USD BILLION)
TABLE 24. ASIA-PACIFIC BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 25. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 26. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY RECOMBINANT HORMONES, BY REGION, 2019-2027 (USD BILLION)
TABLE 27. AMERICAS BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY RECOMBINANT HORMONES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 28. UNITED STATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY RECOMBINANT HORMONES, BY STATE, 2019-2027 (USD BILLION)
TABLE 29. ASIA-PACIFIC BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY RECOMBINANT HORMONES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 30. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY RECOMBINANT HORMONES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 31. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY VACCINES, BY REGION, 2019-2027 (USD BILLION)
TABLE 32. AMERICAS BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY VACCINES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 33. UNITED STATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY VACCINES, BY STATE, 2019-2027 (USD BILLION)
TABLE 34. ASIA-PACIFIC BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY VACCINES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 35. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY VACCINES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 36. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PLATFORM, 2019-2027 (USD BILLION)
TABLE 37. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MAMMALIAN, BY REGION, 2019-2027 (USD BILLION)
TABLE 38. AMERICAS BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MAMMALIAN, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 39. UNITED STATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MAMMALIAN, BY STATE, 2019-2027 (USD BILLION)
TABLE 40. ASIA-PACIFIC BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MAMMALIAN, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 41. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MAMMALIAN, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 42. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MICROBIAL, BY REGION, 2019-2027 (USD BILLION)
TABLE 43. AMERICAS BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MICROBIAL, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 44. UNITED STATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MICROBIAL, BY STATE, 2019-2027 (USD BILLION)
TABLE 45. ASIA-PACIFIC BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MICROBIAL, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 46. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MICROBIAL, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 47. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2019-2027 (USD BILLION)
TABLE 48. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2019-2027 (USD BILLION)
TABLE 49. AMERICAS BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY AUTOIMMUNE DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 50. UNITED STATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY AUTOIMMUNE DISEASES, BY STATE, 2019-2027 (USD BILLION)
TABLE 51. ASIA-PACIFIC BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY AUTOIMMUNE DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 52. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY AUTOIMMUNE DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 53. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2019-2027 (USD BILLION)
TABLE 54. AMERICAS BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 55. UNITED STATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY STATE, 2019-2027 (USD BILLION)
TABLE 56. ASIA-PACIFIC BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 57. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 58. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2019-2027 (USD BILLION)
TABLE 59. AMERICAS BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 60. UNITED STATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY INFECTIOUS DISEASES, BY STATE, 2019-2027 (USD BILLION)
TABLE 61. ASIA-PACIFIC BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 62. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 63. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY METABOLIC DISEASES, BY REGION, 2019-2027 (USD BILLION)
TABLE 64. AMERICAS BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY METABOLIC DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 65. UNITED STATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY METABOLIC DISEASES, BY STATE, 2019-2027 (USD BILLION)
TABLE 66. ASIA-PACIFIC BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY METABOLIC DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 67. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY METABOLIC DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 68. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY NEUROLOGY, BY REGION, 2019-2027 (USD BILLION)
TABLE 69. AMERICAS BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 70. UNITED STATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY NEUROLOGY, BY STATE, 2019-2027 (USD BILLION)
TABLE 71. ASIA-PACIFIC BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 72. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 73. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY ONCOLOGY, BY REGION, 2019-2027 (USD BILLION)
TABLE 74. AMERICAS BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 75. UNITED STATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY ONCOLOGY, BY STATE, 2019-2027 (USD BILLION)
TABLE 76. ASIA-PACIFIC BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 78. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2019-2027 (USD BILLION)
TABLE 79. AMERICAS BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY OPHTHALMOLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 80. UNITED STATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY OPHTHALMOLOGY, BY STATE, 2019-2027 (USD BILLION)
TABLE 81. ASIA-PACIFIC BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY OPHTHALMOLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY OPHTHALMOLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 83. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY RESPIRATORY DISORDERS, BY REGION, 2019-2027 (USD BILLION)
TABLE 84. AMERICAS BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY RESPIRATORY DISORDERS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 85. UNITED STATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY RESPIRATORY DISORDERS, BY STATE, 2019-2027 (USD BILLION)
TABLE 86. ASIA-PACIFIC BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY RESPIRATORY DISORDERS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY RESPIRATORY DISORDERS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 88. AMERICAS BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 89. AMERICAS BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 90. AMERICAS BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 91. AMERICAS BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PLATFORM, 2019-2027 (USD BILLION)
TABLE 92. AMERICAS BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2019-2027 (USD BILLION)
TABLE 93. ARGENTINA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 94. ARGENTINA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 95. ARGENTINA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PLATFORM, 2019-2027 (USD BILLION)
TABLE 96. ARGENTINA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2019-2027 (USD BILLION)
TABLE 97. BRAZIL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 98. BRAZIL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 99. BRAZIL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PLATFORM, 2019-2027 (USD BILLION)
TABLE 100. BRAZIL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2019-2027 (USD BILLION)
TABLE 101. CANADA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 102. CANADA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 103. CANADA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PLATFORM, 2019-2027 (USD BILLION)
TABLE 104. CANADA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2019-2027 (USD BILLION)
TABLE 105. MEXICO BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 106. MEXICO BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 107. MEXICO BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PLATFORM, 2019-2027 (USD BILLION)
TABLE 108. MEXICO BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2019-2027 (USD BILLION)
TABLE 109. UNITED STATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 110. UNITED STATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2019-2027 (USD BILLION)
TABLE 111. UNITED STATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 112. UNITED STATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PLATFORM, 2019-2027 (USD BILLION)
TABLE 113. UNITED STATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2019-2027 (USD BILLION)
TABLE 114. ASIA-PACIFIC BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 115. ASIA-PACIFIC BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 116. ASIA-PACIFIC BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 117. ASIA-PACIFIC BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PLATFORM, 2019-2027 (USD BILLION)
TABLE 118. ASIA-PACIFIC BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2019-2027 (USD BILLION)
TABLE 119. AUSTRALIA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 120. AUSTRALIA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 121. AUSTRALIA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PLATFORM, 2019-2027 (USD BILLION)
TABLE 122. AUSTRALIA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2019-2027 (USD BILLION)
TABLE 123. CHINA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 124. CHINA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 125. CHINA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PLATFORM, 2019-2027 (USD BILLION)
TABLE 126. CHINA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2019-2027 (USD BILLION)
TABLE 127. INDIA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 128. INDIA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 129. INDIA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PLATFORM, 2019-2027 (USD BILLION)
TABLE 130. INDIA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2019-2027 (USD BILLION)
TABLE 131. INDONESIA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 132. INDONESIA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 133. INDONESIA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PLATFORM, 2019-2027 (USD BILLION)
TABLE 134. INDONESIA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2019-2027 (USD BILLION)
TABLE 135. JAPAN BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 136. JAPAN BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 137. JAPAN BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PLATFORM, 2019-2027 (USD BILLION)
TABLE 138. JAPAN BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2019-2027 (USD BILLION)
TABLE 139. MALAYSIA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 140. MALAYSIA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 141. MALAYSIA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PLATFORM, 2019-2027 (USD BILLION)
TABLE 142. MALAYSIA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2019-2027 (USD BILLION)
TABLE 143. PHILIPPINES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 144. PHILIPPINES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 145. PHILIPPINES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PLATFORM, 2019-2027 (USD BILLION)
TABLE 146. PHILIPPINES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2019-2027 (USD BILLION)
TABLE 147. SINGAPORE BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 148. SINGAPORE BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 149. SINGAPORE BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PLATFORM, 2019-2027 (USD BILLION)
TABLE 150. SINGAPORE BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2019-2027 (USD BILLION)
TABLE 151. SOUTH KOREA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 152. SOUTH KOREA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 153. SOUTH KOREA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PLATFORM, 2019-2027 (USD BILLION)
TABLE 154. SOUTH KOREA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2019-2027 (USD BILLION)
TABLE 155. TAIWAN BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 156. TAIWAN BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 157. TAIWAN BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PLATFORM, 2019-2027 (USD BILLION)
TABLE 158. TAIWAN BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2019-2027 (USD BILLION)
TABLE 159. THAILAND BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 160. THAILAND BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 161. THAILAND BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PLATFORM, 2019-2027 (USD BILLION)
TABLE 162. THAILAND BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2019-2027 (USD BILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PLATFORM, 2019-2027 (USD BILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2019-2027 (USD BILLION)
TABLE 168. FRANCE BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 169. FRANCE BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 170. FRANCE BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PLATFORM, 2019-2027 (USD BILLION)
TABLE 171. FRANCE BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2019-2027 (USD BILLION)
TABLE 172. GERMANY BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 173. GERMANY BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 174. GERMANY BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PLATFORM, 2019-2027 (USD BILLION)
TABLE 175. GERMANY BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2019-2027 (USD BILLION)
TABLE 176. ITALY BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 177. ITALY BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 178. ITALY BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PLATFORM, 2019-2027 (USD BILLION)
TABLE 179. ITALY BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2019-2027 (USD BILLION)
TABLE 180. NETHERLANDS BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 181. NETHERLANDS BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 182. NETHERLANDS BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PLATFORM, 2019-2027 (USD BILLION)
TABLE 183. NETHERLANDS BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2019-2027 (USD BILLION)
TABLE 184. QATAR BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 185. QATAR BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 186. QATAR BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PLATFORM, 2019-2027 (USD BILLION)
TABLE 187. QATAR BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2019-2027 (USD BILLION)
TABLE 188. RUSSIA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 189. RUSSIA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 190. RUSSIA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PLATFORM, 2019-2027 (USD BILLION)
TABLE 191. RUSSIA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2019-2027 (USD BILLION)
TABLE 192. SAUDI ARABIA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 193. SAUDI ARABIA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 194. SAUDI ARABIA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PLATFORM, 2019-2027 (USD BILLION)
TABLE 195. SAUDI ARABIA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2019-2027 (USD BILLION)
TABLE 196. SOUTH AFRICA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 197. SOUTH AFRICA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 198. SOUTH AFRICA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PLATFORM, 2019-2027 (USD BILLION)
TABLE 199. SOUTH AFRICA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2019-2027 (USD BILLION)
TABLE 200. SPAIN BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 201. SPAIN BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 202. SPAIN BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PLATFORM, 2019-2027 (USD BILLION)
TABLE 203. SPAIN BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2019-2027 (USD BILLION)
TABLE 204. UNITED ARAB EMIRATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 205. UNITED ARAB EMIRATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 206. UNITED ARAB EMIRATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PLATFORM, 2019-2027 (USD BILLION)
TABLE 207. UNITED ARAB EMIRATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2019-2027 (USD BILLION)
TABLE 208. UNITED KINGDOM BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 209. UNITED KINGDOM BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 210. UNITED KINGDOM BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PLATFORM, 2019-2027 (USD BILLION)
TABLE 211. UNITED KINGDOM BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2019-2027 (USD BILLION)
TABLE 212. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 213. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 214. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 215. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET RANKING
TABLE 216. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2021
TABLE 217. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET MERGER & ACQUISITION
TABLE 218. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 219. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 220. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET INVESTMENT & FUNDING
TABLE 221. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 222. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET: LICENSE & PRICING

Companies Mentioned

  • AbbVie, Inc.
  • Abzena Plc.
  • AGC Biologics
  • Ajinomoto Co., Inc.
  • Avid Bioservices, Inc.
  • Binex Co., Ltd.
  • Boehringer Ingelheim GmbH
  • Cambrex Corporation
  • Catalent, Inc.
  • Emergent BioSolutions Inc.
  • Fujifilm Holding Corporation
  • JSR Life Sciences, LLC
  • Lonza Group AG
  • ProBioGen AG
  • Recipharm AB
  • Rentschler Biotechnologie GmbH
  • Samsung Biologics Co., Ltd.
  • Siegfried Holding AG
  • Thermo Fisher Scientific, Inc.
  • Toyobo Co. Ltd.
  • WuXi Biologics Inc.

Methodology

Loading
LOADING...